Prognostic Enzyme For Nasopharyngeal Cancer Identified
Mayo Clinic Cancer Center scientists, in collaboration with Chinese researchers, have isolated an enzyme that could be used to predict survival and recurrence rates for nasopharyngeal cancer — a common cancer affecting people from Southeast Asia. Results of the study were presented by lead author...
